This issue of EyeWorld Weekly was edited by Stacy Jablonski and Vanessa Caceres. EyeWorld Weekly (ISSN 1089-0319), a digital publication of the American Society of Cataract and Refractive Surgery (ASCRS), is published every Friday, distributed by email, and posted live on Friday. Medical…
➤ Topline results for investigational diabetic retinopathy therapy ➤ Dosing complete in second cohort for Phase 1/2 trial for geographic atrophy therapy ➤ Large data…
Among the important indications for use of the EVO ICL (STAAR Surgical)—age, amount of myopia, astigmatism correction, etc.—there is one parameter that some surgeons say…
Two physicians detailed Ocular Surface Stem Cell Transplantation with Systemic Immunosuppression for the treatment of severe ocular surface disease with limbal stem cell deficiency and…
➤ First patient enrolled in Phase 3 trial evaluating phentolamine ophthalmic solution ➤ FDA clears IND amendment for Phase 3 retinitis pigmentosa gene therapy study…
Identifying and treating patients with limbal stem cell dysfunction or deficiency can be a challenging process. Several physicians discussed how they handle these patients, including…
Peripheral ulcerative keratitis is an inflammatory condition that typically affects the peripheral cornea leading to corneal thinning and corneal melt. It is commonly associated with…
➤ Phase 3 results for new corticosteroid ➤ Positive topline results from Phase 3 trials investigating presbyopia drop ➤ Phase 2 data presented for IOP-lowering…
This column discussed exchanging physical IFU in ophthalmic surgical packaging for e-IFU, as presented in the joint position paper on the use of e-IFU released…
➤ One-year data from first-in-human drug eluting IOL ➤ Company begins two Phase 2 studies for glaucoma treatment ➤ First patient dosed in allogenic cell…
Two cataract surgeons who have dealt with their share of short eyes reviewed their approach. They discussed their methods for lens selection and provided pearls…
